Franklin Resources Inc. Has $1.31 Billion Stock Position in Corteva, Inc. $CTVA

Franklin Resources Inc. increased its stake in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 4.3% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,537,500 shares of the company’s stock after acquiring an additional 805,873 shares during the period. Franklin Resources Inc. owned about 2.89% of Corteva worth $1,309,599,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Drummond Knight Asset Management Pty Ltd bought a new position in Corteva in the 4th quarter valued at about $25,713,000. Alberta Investment Management Corp bought a new position in Corteva in the 3rd quarter valued at about $5,018,000. Avior Wealth Management LLC raised its holdings in Corteva by 464.7% in the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after acquiring an additional 27,075 shares during the period. HighTower Advisors LLC raised its holdings in Corteva by 8.6% in the 3rd quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock valued at $12,352,000 after acquiring an additional 14,436 shares during the period. Finally, Arbejdsmarkedets Tillaegspension bought a new position in Corteva in the 4th quarter valued at about $23,679,000. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of NYSE:CTVA opened at $77.06 on Monday. The company’s 50 day moving average price is $81.17 and its two-hundred day moving average price is $75.01. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The firm has a market cap of $51.54 billion, a PE ratio of 45.33, a PEG ratio of 2.36 and a beta of 0.57. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVAGet Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analyst Ratings Changes

Several research firms have weighed in on CTVA. Deutsche Bank Aktiengesellschaft increased their price target on shares of Corteva from $90.00 to $100.00 in a report on Monday, May 11th. The Goldman Sachs Group increased their price target on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. Berenberg Bank increased their price target on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Mizuho increased their price target on shares of Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Finally, Rothschild & Co Redburn increased their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average price target of $88.67.

Get Our Latest Report on CTVA

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Recommended Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.